Handbook of Growth and Growth Monitoring in Health and Disease 2011
DOI: 10.1007/978-1-4419-1795-9_166
|View full text |Cite
|
Sign up to set email alerts
|

C-Type Natriuretic Peptide (CNP) and Postnatal Linear Growth

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 50 publications
0
2
0
Order By: Relevance
“…Plasma concentrations of CNP forms (i.e. CNP‐22 and NTproCNP) in adults appear to be relatively stable, but the effect of age, gender and anthropometric measures – and changing organ function – in adult subjects has not been studied. Establishing any such relation is clearly important when interpreting values that are now being reported with increasing frequency in a variety of clinical settings .…”
Section: Introductionmentioning
confidence: 99%
“…Plasma concentrations of CNP forms (i.e. CNP‐22 and NTproCNP) in adults appear to be relatively stable, but the effect of age, gender and anthropometric measures – and changing organ function – in adult subjects has not been studied. Establishing any such relation is clearly important when interpreting values that are now being reported with increasing frequency in a variety of clinical settings .…”
Section: Introductionmentioning
confidence: 99%
“…The family shares a ring structure consisting of 17 amino acid residues, flanked by two cysteine residues forming a disulfide bond critical to biological activity (Pandey, 2005 ; Potter et al, 2006 ). Three forms of the peptide occur: expression of the Nppc (Natriuretic Peptide Precursor-C) gene elicits the initial 126 residue preproCNP (Tawaragi et al, 1990 ) resulting in the 103 residue proCNP, which is cleaved intracellularly to produce CNP-53 and a biologically inactive amino terminal fragment, NTproCNP, both of which are secreted extracellularly in equimolar amounts (Wu et al, 2003 ; Prickett and Espiner, 2012 ). Further extracellular processing results in CNP-22, thought to be the fully active form of the peptide, with CNP-53 proposed as a storage form (Barr et al, 1996 ).…”
Section: Introductionmentioning
confidence: 99%